PIA
STJ

Piedmont Investment Advisors’s St Jude Medical STJ Stock Holding History

Piedmont Investment Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-807
Closed -$64.7K – 702
2016
Q4 		$64.7K Buy
807
+803
+20,075% +$63.7K ﹤0.01% 415
2016
Q3 		$319 Hold
4
– – ﹤0.01% 538
2016
Q2 		$312 Buy
+4
New +$285 ﹤0.01% 494

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Piedmont Investment Advisors's STJ Position: Q1 2017 in Review

Piedmont Investment Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 807 shares — an estimated $64.7K sold.

Piedmont Investment Advisors first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $64.7K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Piedmont Investment Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Piedmont Investment Advisors sold 807 St Jude Medical shares in Q1 2017, an estimated $64.7K.
  • Piedmont Investment Advisors first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Piedmont Investment Advisors's St Jude Medical position peaked at $64.7K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Piedmont Investment Advisors's 13F filing for Q1 2017, filed 30 May 2017.